1 study found for:    11294665 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers
Condition: HIV Infections
Interventions: Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: MN rgp120/HIV-1 and A244 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205);   Biological: rgp120/HIV-1 SF-2

Indicates status has not been verified in more than two years